Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0473 per EA under NDC 50111045602. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111045602
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071655On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 88.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.4105 (Feb 12, 2014) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.1262 |
| Average price | $0.1834 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0473 per EA (NDC 50111045602), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 88.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Nov 28, 2013, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.4105 (Feb 12, 2014), with a median of $0.1262 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 50111045602) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification